EUVIMEDEUVIMED entdecken
Open Access · CC BY-SA 4.0

PHOTOTHERMAL THERAPY OF TRIPLE-NEGATIVE BREAST CANCER USING FOLIC ACID-TARGETED GOLD NANORODS

David Mayers, Jemima Reid, Shannon Thompson

Journal of Biomedical and Techno Nanomaterials · 17.12.2025 · 2 (6) · 368-379

DOI: 10.70177/jbtn.v2i6.2981 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biomedical and Techno Nanomaterials, online erschienen am 17.12.2025. Verfasst von David Mayers und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype characterized by the absence of hormone receptors and HER2 expression, resulting in limited therapeutic options and poor clinical prognosis. Conventional treatments such as chemotherapy often lack selectivity and are associated with significant systemic toxicity, highlighting the urgent need for more precise and effective therapeutic strategies. This study aims to develop and evaluate folic acid–targeted gold nanorods as a photothermal therapy platform for selective treatment of TNBC. An experimental nanomedicine approach was employed, involving the synthesis of gold nanorods, surface functionalization with folic acid to enable folate receptor–mediated targeting, physicochemical characterization, and biological evaluation in TNBC models. Photothermal performance was assessed under near-infrared laser irradiation, while cellular uptake, cytotoxicity, and therapeutic selectivity were systematically analyzed. The results demonstrate that folic acid functionalization significantly enhanced nanoparticle uptake by TNBC cells, leading to higher localized temperature elevation and pronounced cancer cell ablation compared to non-targeted nanorods. Minimal cytotoxic effects were observed in normal breast cells, indicating favorable selectivity. In conclusion, folic acid–targeted gold nanorods provide an effective and selective photothermal therapy strategy for TNBC. This approach shows strong potential for advancing targeted nanomedicine and offers a promising alternative for treating aggressive breast cancer subtypes.

Zitieren

APA

Mayers, D., Reid, J., & Thompson, S. (2025). PHOTOTHERMAL THERAPY OF TRIPLE-NEGATIVE BREAST CANCER USING FOLIC ACID-TARGETED GOLD NANORODS. Journal of Biomedical and Techno Nanomaterials, 2(6), 368-379. https://doi.org/10.70177/jbtn.v2i6.2981

Vancouver

Mayers D, Reid J, Thompson S. PHOTOTHERMAL THERAPY OF TRIPLE-NEGATIVE BREAST CANCER USING FOLIC ACID-TARGETED GOLD NANORODS. Journal of Biomedical and Techno Nanomaterials. 2025;2(6):368-379. doi:10.70177/jbtn.v2i6.2981

BibTeX
@article{Mayers2025,
  author = {Mayers, David and Reid, Jemima and Thompson, Shannon},
  title = {PHOTOTHERMAL THERAPY OF TRIPLE-NEGATIVE BREAST CANCER USING FOLIC ACID-TARGETED GOLD NANORODS},
  journal = {Journal of Biomedical and Techno Nanomaterials},
  year = {2025},
  volume = {2},
  number = {6},
  pages = {368--379},
  doi = {10.70177/jbtn.v2i6.2981}
}
Kostenlos starten →